Hepatic transcriptome signatures in patients with varying degrees of non-alcoholic fatty liver disease compared to healthy normal-weight individuals.

In conclusion, application of immunohistochemical markers of hepatocyte injury may serve as a more objective tool for distinguishing NASH from NAFL, facilitating improved resolution of hepatic molecular changes associated with progression of NAFLD. PMID: 30653341 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30653341?dopt=Abstract

Source: Am J Physiol Gastroi... - January 17, 2019 Category: Gastroenterology Authors: Suppli MP, Rigbolt KTG, Veidal SS, Heebøl S, Lykke Eriksen P, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK Tags: Am J Physiol Gastrointest Liver Physiol Source Type: research